eFFECTOR Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
eFFECTOR Therapeutics has a total shareholder equity of $827.0K and total debt of $20.0M, which brings its debt-to-equity ratio to 2420.3%. Its total assets and total liabilities are $27.1M and $26.3M respectively.
Key information
2,420.3%
Debt to equity ratio
US$20.02m
Debt
| Interest coverage ratio | n/a |
| Cash | US$25.38m |
| Equity | US$827.00k |
| Total liabilities | US$26.30m |
| Total assets | US$27.13m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: LWK's short term assets ($26.3M) exceed its short term liabilities ($25.6M).
Long Term Liabilities: LWK's short term assets ($26.3M) exceed its long term liabilities ($735.0K).
Debt to Equity History and Analysis
Debt Level: LWK has more cash than its total debt.
Reducing Debt: Insufficient data to determine if LWK's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: LWK has sufficient cash runway for 10 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: LWK is forecast to have sufficient cash runway for 10 months based on free cash flow estimates, but has since raised additional capital.